Ledger.Open graph →
SEC Form D · filed May 19, 2023

Aviceda Therapeutics, Inc

Offering
$15.6M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Patrick Johnson · Cambridge, MADirectorMohamed Genead · Cambridge, MAExec · DirectorNancy Thomason · Cambridge, MADirectorMichael Tolentino · Cambridge, MADirectorChristoph Adams · Cambridge, MADirectorJonathan S. Spencer · New York, NYDirectorPaul Vukelic · Cambridge, MADirectorGrant B. Cellier · George Town, Cayman IslandsDirectorPaul Vukelic · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗